UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044746
Receipt number R000051085
Scientific Title Development of an evaluation system for chronic kidney disease using functional MRI (magnetic resonance imaging) and machine learning
Date of disclosure of the study information 2021/07/15
Last modified on 2024/07/27 19:07:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of an evaluation system for chronic kidney disease using functional MRI (magnetic resonance imaging) and machine learning

Acronym

Development of an evaluation system for chronic kidney disease using functional MRI (magnetic resonance imaging) and machine learning

Scientific Title

Development of an evaluation system for chronic kidney disease using functional MRI (magnetic resonance imaging) and machine learning

Scientific Title:Acronym

Development of an evaluation system for chronic kidney disease using functional MRI (magnetic resonance imaging) and machine learning

Region

Japan


Condition

Condition

Chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Diagnosis of disease, assessment of pathophysiological status, and detection of early progressors

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Annual rate of decline in estimated glomerular filtration rate

Key secondary outcomes

Estimated glomerular filtration rate, urinary protein levels and other urine and blood test results


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A chronic kidney disease patient who underwent MRI at Saitama Medical University for the diagnosis of chronic kidney disease.

Key exclusion criteria

After the introduction of renal replacement therapy, children, acute kidney injury, unilateral kidney disease (such as renovascular hypertension), kidney tumors, nephrotic syndrome, cystic disease, and postrenal renal failure

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Hirokazu
Middle name
Last name Okada

Organization

Saitama Medical University

Division name

Department of Nephrology

Zip code

350-0495

Address

38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan

TEL

0492761611

Email

hirookda@saitama-med.ac.jp


Public contact

Name of contact person

1st name Hirokazu
Middle name
Last name Okada

Organization

Saitama Medical University

Division name

Department of Nephrology

Zip code

350-0495

Address

38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan

TEL

0492761611

Homepage URL


Email

hirookda@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University

Address

38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan

Tel

0492761354

Email

hirb@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

300

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Due to the time required for analysis.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 06 Month 07 Day

Date of IRB

2021 Year 06 Month 07 Day

Anticipated trial start date

2021 Year 06 Month 07 Day

Last follow-up date

2021 Year 06 Month 07 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A non-interventional, retrospective observational study. Total sampling for cases meeting the inclusion criteria. To examine the relationship between MRI, clinical data (blood and urine test), and annual changes in estimated glomerular filtration rate.


Management information

Registered date

2021 Year 07 Month 03 Day

Last modified on

2024 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051085